跳至主要内容
临床试验/NCT06352515
NCT06352515尚未招募不适用

Peripheral Blood T Lymphocyte Subsets in Ulcerative Colitis

Assiut University0 个研究点目标入组 80 人开始时间: 2024年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
80
主要终点
Correlation of T-cell subtypes to therapeutic response

研究概览

简要总结

  1. Study the distribution of peripheral blood T lymphocyte subsets among ulcerative colitis patients.
  2. Correlation of T-cell subsets to therapeutic response/ disease activity.
  3. Assess the value of circulating IgG anti-Integrin αvβ6 in UC.

详细描述

Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disease of the large intestine, frequently involving the rectum, and characterized by chronic and recurrent mucosal inflammation and ulceration. Although its cause is not well understood, current evidence suggests innate and adaptive immunity play critical roles in its pathogenesis.

One of the main classes of immune cells that are affected by and contribute to UC is T cells. T-lymphocytes comprise a complex collection of highly differentiated T-cell subsets playing key roles in the regulation and the effector phase of the immune response. CD4+ T cells were found over-activated and proliferated in UC patients, which can induce disorders of the cytokine network and increase the occurrence of colitis.

Once intestinal pathogens or inflammatory mediators are not cleared in time, pro-inflammatory mononuclear phagocytes (MNPs) or polymorphonuclear leukocytes (PMNs) are often recruited to promote the polarization of naive CD4+ T cells into Th1, Th2, Th17, Treg and other subsets of cells.

The balances Th17/ Treg cells are important for maintaining intestinal homeostasis. Once the proportion Th17 cells increases, it often induces the production of pro-inflammatory cytokines that promote colonic inflammation, whereas Treg cells are usually secrete interleukin-10 (IL-10) and transforming growth factor-β (TGF-β) for anti-inflammatory regulations.

UC-associated inflammation is also characterized by huge number of activated B cells and plasma cells, the latter being involved in the production of cytotoxic granules, immunoglobulins, and various autoantibodies, Recent studies have highlighted a novel autoantibody against integrin αvβ6 in the serum of patients diagnosed with UC.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with clinical diagnosis of ulcerative colitis among both sexes.
  • Age >18 years Old.

排除标准

  • Age <18 years old.
  • Patients who refuse to participate in the study.
  • Patients who have other autoimmune disease.

结局指标

主要结局

Correlation of T-cell subtypes to therapeutic response

时间窗: 3 years

Determine the effect of different treatment strategies used in UC on T-lymphocyte subsets

Study the distribution of T-cell subsets among ulcerative colitis patients.

时间窗: 3 years

Investigate and compare the distribution of different T-lymphocyte subsets among ulcerative colitis patients and healthy subjects .

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amany Abdelkader Ahmed

Assistant Lecturer

Assiut University

相似试验